Pàgina inicial > Resultats de la cerca: CD20
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 6 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Documents de recerca, 1 registres trobats
Articles 5 registres trobats  
1.
7 p, 817.8 KB Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis : results from the HEBEM study / Marzo Escartin, Blanca (Universitat Autònoma de Barcelona. Departament de Medicina) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Robles-Sanchez, Miguel-Angel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Buti, Maria (Universitat Autònoma de Barcelona. Departament de Medicina) ; Riveiro Barciela, Mar (Universitat Autònoma de Barcelona. Departament de Medicina)
INTRODUCTION: Prospective data on the risk of hepatitis B reactivation (HBVr) among patients with resolved HBV infection undergoing anti-CD20 antibodies monotherapy is scarce. We aimed to assess the risk of HBVr in patients with resolved HBV infection treated with rituximab or ocrelizumab in monotherapy for multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) without antiviral prophylaxis. [...]
D. Steinkopff-Verlag, 2023 - 10.1007/s00415-023-11973-y
Journal of Neurology, Vol. 271 (2024) p. 134-140  
Registre complet - Creative Commons
2.
14 p, 1.3 MB Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99 / Galadima, Makchit (Sciomics GmbH) ; Kotova, Iuliia (Sciomics GmbH) ; Schmidt, Ronny (Sciomics GmbH) ; Pastor Milán, Josep (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Schröder, Christoph (Sciomics GmbH) ; Rodríguez Gil, Joan Enric (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Rivera del Álamo, Maria Montserrat (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals)
The idea of using tumour biomarkers as diagnostic tools is progressively increasing. Of these, serum biomarkers are of particular interest, as they can provide rapid results. In the present study, serum samples from 26 bitches diagnosed with mammary tumours, plus 4 healthy bitches, were obtained. [...]
2023 - 10.3390/ijms24119222
International journal of molecular sciences, Vol. 24 Núm. 11 (2023) , p. 9222-14  
Registre complet - Creative Commons
3.
18 p, 436.4 KB COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
Introduction: The SARS-CoV-2 pandemic necessitated better understanding of the impact of disease-modifying therapies on COVID-19 outcomes and vaccination. We report characteristics of COVID-19 cases and vaccination status in ofatumumab-treated relapsing multiple sclerosis (RMS) patients. [...]
2022 - 10.1007/s40120-022-00341-z
Neurology and Therapy, Vol. 11 Núm. 2 (june 2022) , p. 741-758  
Registre complet - Creative Commons
4.
4 p, 243.1 KB Correction to : COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab / Cross, Anne H. (Department of Neurology. Washington University) ; Delgado, Silvia (University of Miami Miller School of Medicine) ; Habek, Mario (University Hospital Center Zagreb. University of Zagreb. School of Medicine) ; Davydovskaya, Maria (Moscow State Public Healthcare InsCity Clinical Hospital 24) ; Ward, Brian J. (Infectious Diseases Division. Research Institute of the McGill University Health Centre) ; Cree, Bruce A. C (UCSF Weill Institute for Neurosciences. Department of Neurology. University of California San Francisco) ; Totolyan, Natalia (First Saint Petersburg State Medical University) ; Pingili, Ratnakar (Novartis Pharmaceuticals Corporation) ; Mancione, Linda (Novartis Pharmaceuticals Corporation) ; Hu, Xixi (Novartis Pharmaceuticals Corporation) ; Sullivan, Roseanne (Novartis Pharmaceuticals Corporation) ; Su, Wendy (Novartis Pharmaceuticals Corporation) ; Zielman, Ronald (Novartis Pharma B.V.) ; Gupta, Ayan Das (Novartis Healthcare Private Limited) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Winthrop, Kevin (School of Public Health at Oregon Health and Science University) ; Universitat Autònoma de Barcelona. Departament de Medicina
2022 - 10.1007/s40120-022-00346-8
Neurology and Therapy, Vol. 11 Núm. 2 (2022) , p. 759-762  
Registre complet - Creative Commons
5.
15 p, 4.6 MB Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab / Serra-Peinado, Carla (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Grau Expósito, Judith (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Luque-Ballesteros, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Astorga-Gamaza, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Navarro, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gallego-Rodriguez, Jenny (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martín Castillo, Mario (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Curran, Adrian (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Burgos, Joaquín (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ribera, Esteban (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Raventós, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Willekens, Rein (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Torrella Domingo, Adriana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Planas, Bibiana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Badía, Rosa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García, Felipe (Hospital Clínic i Provincial de Barcelona) ; Castellvi, Josep (Hospital Universitari Vall d'Hebron) ; Genescà Ferrer, Meritxell (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Falcó, Vicenç (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Buzón, Maria José (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The identification of exclusive markers to target HIV-reservoir cells will represent a significant advance in the search for therapies to cure HIV. Here, we identify the B lymphocyte antigen CD20 as a marker for HIV-infected cells in vitro and in vivo. [...]
2019 - 10.1038/s41467-019-11556-4
Nature communications, Vol. 10 Núm. 1 (january 2019) , p. 3705  
Registre complet - Creative Commons

Documents de recerca 1 registres trobats  
1.
1 p, 563.6 KB Anticossos monoclonals anti-CD20 per al tractament del limfoma no-Hodgkin / Noguera Ballester, Mercè ; Álvarez Pérez, Iñaki, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Microbiologia [816]  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem